Lumibird: sales up by almost 7% in 2023
The level of sales achieved in the fourth quarter (64.6 million) should enable the group to confirm its mid-December 2023 adjusted target of an EBITDA margin in excess of 17% on a like-for-like basis.
Lumibird adds that it is 'maintaining its growth trajectory, driven by the momentum of its key markets (defense/space, medical)' and 'anticipates more profitable growth in the coming years, as it reaps the rewards of its investments'.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction